Exercise Ventilatory Inefficiency Adds to Lung Function in Predicting Mortality in COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 13, Issue 4, 2016, Pages 416-424

  Neder, J Alberto ^a,b   Alharbi, Abdullah ^a   Berton, Danilo C ^c   Alencar, Maria Clara N ^b   Arbex, Flavio F ^b   Hirai, Daniel M ^a,b   Webb, Katherine A ^a   O'Donnell, Denis E ^a  

^a KINGSTON GENERAL HOSPITAL   (Canada)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Survival; COPD; ventilation; cardiopulmonary exercise test; physiology

Indexed keywords

BRONCHODILATING AGENT; CARBON DIOXIDE; CARBOXYHEMOGLOBIN; CORTICOSTEROID; ROFLUMILAST;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDUAL VOLUME; SURVIVAL; TOTAL LUNG CAPACITY; AGE; BODY PLETHYSMOGRAPHY; CAUSE OF DEATH; COMPLICATION; EXERCISE; EXERCISE TEST; KAPLAN MEIER METHOD; LUNG DIFFUSION CAPACITY; LUNG VENTILATION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPIROMETRY; STATISTICAL MODEL; SURVIVAL RATE;

AGE FACTORS; AGED; BODY MASS INDEX; CARBON DIOXIDE; CAUSE OF DEATH; COMORBIDITY; DYSPNEA; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INSPIRATORY CAPACITY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MORTALITY; PLETHYSMOGRAPHY, WHOLE BODY; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY VENTILATION; RESIDUAL VOLUME; SPIROMETRY; SURVIVAL RATE; TOTAL LUNG CAPACITY;

EID: 84963548193     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2016.1158801     Document Type: Article

References (40)

1. J.Vestbo, S.S.Hurd, A.AGAgustí, P.W.Jones, C.Vogelmeier, A.Anzueto, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187(4):347–365.
2. A.K.Boutou, D.Shrikrishna, R.J.Tanner, C.Smith, J.L.Kelly, S.P.Ward, et al. Lung function indices for predicting mortality in COPD. Eur Respir J 2013; 42(3):616–625.
3. B.R.Celli, M.Decramer, J.A.Wedzicha, K.C.Wilson, A.AAgustí, G.J.Criner, et al. An official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 191(7):e4–27.
4. C.Casanova, C.Cote, J.P.de Torres, A.Aguirre-Jaime, J.M.Marin, V.Pinto-Plata, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(6):591–597.
5. B.R.Celli. Predictors of mortality in COPD. Respir Med 2010; 104(6):773–779.
6. D.E.O'Donnell, P.Laveneziana, K.Webb, J.A.Neder. Chronic obstructive pulmonary disease: clinical integrative physiology. Clin Chest Med 2014; 35(1):51–69.
7. E.R.S.Task Force, P.Palange, S.A.Ward, K.-H.Carlsen, R.Casaburi, C.G.Gallagher, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29(1):185–209.
8. J.P.de Torres, C.Casanova, J.M.Marín, V.Pinto-Plata, M.Divo, J.J.Zulueta, et al. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE. Thorax 2014; 69(9):799–804.
9. E.Teopompi, P.Tzani, M.Aiello, M.R.Gioia, E.Marangio, A.Chetta. Excess ventilation and ventilatory constraints during exercise in patients with chronic obstructive pulmonary disease. Respir Physiol Neurobiol 2014; 197:9–14.
10. J.A.Guenette, R.C.Chin, S.Cheng, P.B.Dominelli, N.Raghavan, K.A.Webb, et al. Mechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPD. Eur Respir J 2014; 44(5):1177–87.
11. J.A.Neder, F.F.Arbex, M.C.N.Alencar, C.D.J.O'Donnell, J.Cory, K.A.Webb, et al. Exercise ventilatory inefficiency in mild to end-stage COPD. Eur Respir J 2015; 45(2):377–87.
12. B.J.Whipp, S.A.Ward, K.Wasserman. Ventilatory responses to exercise and their control in man. Am Rev Respir Dis 1984; 129(2 Pt 2):S17–S20.
13. S.A.Ward Ventilatory control in humans: constraints and limitations. Exp Physiol 2007; 92(2):357–366.
14. P.Paoletti, F.De Filippis, F.Fraioli, A.Cinquanta, G.Valli, P.Laveneziana, et al. Cardiopulmonary exercise testing (CPET) in pulmonary emphysema. Respir Physiol Neurobiol 2011; 179(2–3):167–173.
15. R.Rodríguez-Roisin, M.Drakulovic, D.A.Rodríguez, J.Roca, B.JABarberà, P.D.Wagner. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol Bethesda 2009; 106(6):1902–1908.
16. D.E.O'Donnell, J.A.Guenette, F.Maltais, K.A.Webb. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest 2012; 141(3):753–762.
17. A.K.Boutou, A.Nair, D.Douraghi-Zadeh, R.Sandhu, D.M.Hansell, A.U.Wells, et al. A combined pulmonary function and emphysema score prognostic index for staging in chronic obstructive pulmonary disease. PloS One 2014; 9(10):e111109.
18. S.Holverda, H.J.Bogaard, H.Groepenhoff, P.E.Postmus, A.Boonstra, A.Vonk-Noordegraaf. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respir Int Rev Thorac Dis 2008; 76(2):160–167.
19. P.Gagnon, J.S.Bussières, F.Ribeiro, S.L.Gagnon, D.Saey, G.NGagné, et al. Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186(7):606–615.
20. P.Ponikowski, W.Banasiak. Chemosensitivity in chronic heart failure. Heart Fail Monit 2001; 1(4):126–131.
21. E.V.M.Ferreira, J.S.Ota-Arakaki, R.P.Ramos, P.B.Barbosa, M.Almeida, E.C.Treptow, et al. Optimizing the evaluation of excess exercise ventilation for prognosis assessment in pulmonary arterial hypertension. Eur J Prev Cardiol 2014; 21(11):1409–1419.
22. J.Myers, R.Arena, R.B.Oliveira, D.Bensimhon, L.Hsu, P.Chase, et al. The lowest VE/VCO2 ratio during exercise as a predictor of outcomes in patients with heart failure. J Card Fail 2009; 15(9):756–762.
23. X.-G.Sun, J.E.Hansen, N.Garatachea, T.W.Storer, K.Wasserman. Ventilatory efficiency during exercise in healthy subjects. Am J Respir Crit Care Med 2002; 166(11):1443–1448.
24. D.A.Mahler, D.H.Weinberg, C.K.Wells, A.R.Feinstein. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85(6):751–758.
25. M.E.Charlson, P.Pompei, K.L.Ales, C.R.MacKenzie. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5):373–383.
26. E.R.DeLong, D.M.DeLong, D.L.Clarke-Pearson. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44(3):837–845.
27. L.Ingle, R.Sloan, S.Carroll, K.Goode, J.G.Cleland, A.L.Clark. Prognostic significance of different measures of the ventilation-carbon dioxide relation in patients with suspected heart failure. Eur J Heart Fail 2011; 13(5):537–542.
28. A.F.Elbehairy, C.E.Ciavaglia, K.A.Webb, J.A.Guenette, D.Jensen, S.M.Mourad, et al. Pulmonary gas exchange abnormalities in mild chronic obstructive pulmonary disease. Implications for dyspnea and exercise intolerance. Am J Respir Crit Care Med 2015; 191(12):1384–1394.
29. T.Oga, K.Nishimura, M.Tsukino, S.Sato, T.Hajiro. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167(4):544–549.
30. A.Apostolo, P.Laveneziana, P.Palange, C.Agalbato, R.Molle, D.Popovic, et al. Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Int J Cardiol 2015; 189:134–140.
31. P.Gargiulo, A.Apostolo, P.Perrone-Filardi, S.Sciomer, P.Palange, P.Agostoni. A non invasive estimate of dead space ventilation from exercise measurements. PloS One 2014; 9(1):e87395.
32. K.Hueper, J.Vogel-Claussen, M.A.Parikh, J.H.M.Austin, D.A.Bluemke, J.Carr, et al. Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD Study. Am J Respir Crit Care Med 2015; 192(5):570–580.
33. B.M.Smith, E.A.Hoffman, R.C.Basner, S.M.Kawut, R.Kalhan, R.G.Barr. Not all measures of hyperinflation are created equal: lung structure and clinical correlates of gas trapping and hyperexpansion in COPD: the multi-ethnic study of atherosclerosis (MESA) COPD study. Chest 2014; 145(6):1305–1315.
34. K.Vonbank, G.C.Funk, B.Marzluf, B.Burian, R.Ziesche, L.Stiebellehner, et al. Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. Wien Klin Wochenschr 2008; 120(23–24):749–755.
35. H.F.Armstrong, N.E.Dussault, W.Thirapatarapong, R.S.Lemieux, B.M.Thomashow, M.N.Bartels. Ventilatory efficiency before and after lung volume reduction surgery. Respir Care 2015; 60(1):63–71.
36. V.Kim, D.M.Kretschman, A.L.Sternberg, M.M.DeCamp, G.J.Criner, National Emphysema Treatment Trial Research Group. Weight gain after lung reduction surgery is related to improved lung function and ventilatory efficiency. Am J Respir Crit Care Med 2012; 186(11):1109–1116.
37. R.G.Barr The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema. Proc Am Thorac Soc 2011; 8(6):522–527.
38. M.A.Thomashow, D.Shimbo, M.A.Parikh, E.A.Hoffman, J.Vogel-Claussen, K.Hueper, et al. Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The multi-ethnic study of atherosclerosis chronic obstructive pulmonary disease study. Am J Respir Crit Care Med 2013; 188(1):60–68.
39. D.E.O'Donnell, C.M.Parker. COPD exacerbations. 3: Pathophysiology. Thorax 2006; 61(4):354–361.
40. A.Barron, N.Dhutia, J.Mayet, A.D.Hughes, D.P.Francis, R.Wensel. Test-retest repeatability of cardiopulmonary exercise test variables in patients with cardiac or respiratory disease. Eur J Prev Cardiol 2014; 21(4):445–453.